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Triggering the TCR Complex Causes
the Downregulation of Nonengaged Receptors
by a Signal Transduction-Dependent Mechanism
superantigens or the cross-linking of the TCR complex
with anti-TCR or anti-CD3 antibodies results in the rapid
downregulation of the complex. Receptor downregula-
tion is a common phenomenon shared by other mem-
brane receptors with associated or intrinsic tyrosine ki-
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nase activity (Seaman et al., 1996). The internalizationCantoblanco
of signal-transducing receptors is thought to produce28049 Madrid
a dual effect. First, it may contribute to signal transduc-Spain
tion by favoring the encounter between receptor and²UniteÂ de Biologie des Interactions Cellulaires
intracellular signaling molecules (Rothenberg, 1996; Lu-Institut Pasteur
ton et al., 1997). Second, it may contribute to the termi-28 Rue du Docteur Roux
nation of cellular responses by reducing the number of75724 Paris Cedex 15
receptors at the cell surface or by uncoupling receptorsFrance
from membrane-anchored signaling molecules (Cai et
al., 1997). This latter effect is supported by the observa-
tion that TCR downregulation results in a loss of cellularSummary
sensitivity to subsequent stimulation (Zanders et al.,
1983; Schonrich et al., 1991; Valitutti et al., 1996). Fur-Downregulation of the TCR complex is believed to
ther, the inhibition of receptor downregulation by ex-be intimately tied to T cell activation, allowing serial
pression of a dominant-negative Rab5 mutant leads totriggering of receptors and desensitization of stimu-
enhanced signaling (Andre et al., 1997). In addition, TCRlated cells. We studied transfected and transgenic T
internalization plays an important role during T cell acti-cells expressing CD3z chimeras to demonstrate that
vation by allowing serial triggering of multiple TCR com-ligand engagement of the TCR or chimeras causes
plexes by a few antigen/MHC complexes (Valitutti andcomodulation of nonengaged receptors. Comodula-
Lanzavecchia, 1997).tion required protein tyrosine kinase activity but not
Although a full consensus has not been reached, mul-trans-phosphorylation of nonengaged receptors. The
tiple mechanisms seem to mediate the downregulationTCR appears to be downregulated by at least two
of the TCR complex. CD3g possesses within its cyto-mechanisms. One mechanism requires direct engage-
plasmic tail a serine- and double leucine-containing mo-ment, independent of signaling. The second requires
tif that is required for PKC-mediated TCR downregula-signaling and downregulates nontriggered receptors.
tion. However, this motif and even the entire cytoplasmicThese results shed new light on the process of TCR
tail of CD3g appear to be dispensable for ligand-induceddownregulation and indicate that the number of down-
TCR downregulation, suggesting that mechanisms other
regulated TCRs cannot be assumed to equal the num-
than phosphorylation of CD3g by PKC are partly respon-
ber of engaged receptors. sible. The sensitivity of TCR dowregulation to PTK inhibi-
tors has led some authors to conclude that PTKs are
Introduction involved (Luton et al., 1994; Martin and Bevan, 1998).
Other authors, however, have detected the downregula-
T cells respond to antigen via a polypeptide complex tion of the TCR complex in a PTK-independent fashion
composed of the ligand-binding T cell receptor (TCR) a (Cai et al., 1997; Salio et al., 1997). Both findings are
and b chains (or g and d in gd T cells) and the CD3 consistent with the idea that the TCR complex may be
subunits CD3g, CD3d, CD3e, and CD3z (Clevers et al., modulated by a combination of PTK-dependent and
1988; Malissen and Schmitt-Verhulst, 1993). Unlike the -independent mechanisms.
TCR chains, the CD3 components have long cyto- It has been previously shown that TCR downregula-
tion could involve engaged as well as nonengaged re-plasmic tails that are responsible for the association
ceptors (Exley et al., 1995; Niedergang et al., 1997; Fer-with cytoplasmic signaling proteins. This association is
nandez-Miguel et al., 1999). This comodulation maymediated at least in part by a double tyrosine-based
originate from the physical association between en-motif present in single copy in the CD3g, d, and e chains
gaged and nonengaged receptors (Exley et al., 1995;and in three copies in CD3z (Reth, 1989). This motif,
Fernandez-Miguel et al., 1999) or from a trans-actingnamed immune receptor tyrosine-based activation motif
signaling mechanism that does not require physical in-(ITAM), becomes tyrosine phosphorylated during T cell
teraction with engaged receptors (Niedergang et al.,activation (reviewed by Cantrell, 1996; Alberola-Ila et al.,
1997, 1998). In order to elucidate the role of trans-acting1997; Qian and Weiss, 1997).
signaling in the downregulation of nonengaged recep-The interaction between TCRs and peptide/MHC or
tors, we used both T cell transfectants and T cells de-
rived from transgenic mice which express membrane³ To whom correspondence should be addressed (e-mail: balarcon@
protein chimeras that contain the cytoplasmic tail ofcbm.uam.es).
CD3z or one of its ITAMs. Cross-linking either chimera§ These authors contributed equally to this work.
with antibodies caused the comodulation of TCR com-k Present address: ISREC, Institut de Biochimie, UniversiteÂ de Lau-
sanne, CH-1066, Epalinges, Switzerland. plexes. Conversely, engagement of the TCR complex
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with antibodies, antigen, or superantigen caused comod- that the in vitro stimulation of T cells from TTz transgenic
mice with immobilized antibodies causes the comodula-ulation of the CD3z chimera. Since this model does not
tion of the nonengaged receptor. To determine whetherallow for physical interaction between the TCR complex
the same phenomenon can be observed upon engage-and the chimeric receptors, we propose that trans-act-
ment of the TCR in vivo, TTz transgenic mice were in-ing intracellular second messengers mediate the comod-
jected intravenously with a superantigen, Staphylococ-ulation effect. In contrast, downregulation of directly
cus aureus enterotoxin B (SEB). The effect of SEB onengaged receptors was signal independent. These find-
the downregulation of the TCR complex was studiedings support the idea that TCR downregulation occurs
with F23.1, an antibody that recognizes Vb8-expressingvia distinctly different mechanisms and directly affects
TCRbs, one of the major TCRb families engaged bythe calculation of the number of serial triggering events.
SEB. As expected, the injection of SEB caused a strong
downregulation of the TCR complex in F23.1-positiveResults
cells and, importantly, resulted in the downregulation
of the TTz chimera. This result demonstrates that theComodulation of CD3z-Containing Protein
mechanism that mediates the comodulation of the TTzChimeras with the TCR Complex
chimera upon TCR triggering also operates in vivo andA transgenic mouse line expressing a TTz chimera was
thus is not an artifact of ex vivo cell cultures.used to elucidate whether there is cross-talk between
In order to study the mechanisms that mediate thisthe TCR complex and CD3z chimeras, which may allow
comodulation, a Jurkat cell clone was used that ex-comodulation when one of the receptors is engaged by
presses both the TTz chimera and the TCRa and TCRbligands. The TTz chimera is comprised of the extracellu-
(Vb3) chains from a human T cell clone (HA 1.7), whichlar and transmembrane domains of CD25 (Tac) fused to
render the clone responsive to an influenza hemaggluti-the cytoplasmic tail of CD3z. Stimulation of T cell blasts
nin peptide presented by DR1 and SEB. The stimulationfrom transgenic mice spleens with immobilized anti-CD3
of the Jurkat TTz clone with anti-Tac antibody resultedantibody resulted in TCR complex downregulation (Fig-
in the comodulation of the TCR complex. Also, TCRure 1A) as well as downregulation of the TTz chimera.
engagement with antibody (anti-CD3), superantigenThis effect was reciprocal in that stimulation with anti-
(SEB), or nominal antigen (HA-DR1) resulted in the co-Tac of the TTz chimera resulted in the comodulation of
modulation of the TTz chimera (Figure 2A). As noted pre-the TCR complex (Figure 1A). The downregulation of the
viously in our transgenic model, the extent of comodula-TCR complex when T cell blasts were stimulated with
tion of the TTz chimera was not directly related to theanti-Tac was maximal after 2 hr of incubation (Figure
level of TCR downregulation. The level of TTz downregu-1B). However, the downregulation of the TTz chimera
lation achieved following stimulation by HA-DR1 anti-continued increasing even after 6 hr. The disparity in
gen, immobilized anti-CD3 antibody, or SEB was higherthe downregulation rates of the directly engaged recep-
than, lower than, or parallel to that of the TCR complex,tor (TTz) by anti-Tac and the nonengaged receptor (TCR)
respectively (Figure 2A). In addition, the time points ofsuggests that both are downregulated by different
maximal downregulation of the directly engaged and
mechanisms. The comodulation effect on the TCR com-
the comodulated receptors were different. For example,
plex by stimulation of the TTz chimera was restricted to
anti-Tac stimulation resulted in maximal downregulation
the TCR complex, since CD4 (Figure 1B, blasts) and
of TTz at 60 min and of TCR at 30 min. Although in
other membrane receptors, including CD5, CD7, CD8, theory the observed comodulation effects could be a
and CD28 (data not shown), were not downregulated. consequence of a physical interaction between the re-
The downregulation of TCR upon stimulation of TTz with ceptors, this scenario is unlikely since the cytoplasmic
anti-Tac was always lower than the downregulation of tail of CD3z, which is present in the TTz chimera, is not
TTz. Interestingly, the stimulation of TCR with anti-CD3 involved in TCR assembly (Frank et al., 1990; Rutledge et
antibodies frequently resulted in higher downregulation al., 1992; Shores et al., 1994). Nevertheless, to determine
of TTz than of the directly engaged TCR (Figure 1B, whether TTz and the TCR complex directly interact, an
blasts). This finding suggests that (1) the signal for immunoprecipitation experiment under gentle extrac-
downregulation of TTz may be stronger than that of the tion conditions was performed. The immunoprecipita-
TCR complex, irregardless of which receptor is directly tion with anti-Tac and anti-CD3 antibodies was followed
engaged, or (2) since the direct downregulation is sur- by immunoblotting with an anti-CD3z antibody that rec-
passed by the comodulatory effect under certain condi- ognizes both CD3z and the TTz chimera. The immuno-
tions, the comodulation effect could represent a signifi- precipitation with anti-Tac isolated the TTz chimera but
cant proportion of total downregulation. did not result in the coprecipitation of CD3z. Similarly,
To determine whether the comodulation of the TCR the immunoprecipitation with anti-CD3 antibody iso-
complex and TTz could be observed in resting T cells, lated CD3z but not TTz. Immunoprecipitation from SEB-
freshly isolated spleen cells were stimulated with immo- stimulated Jurkat clones demonstrated similar results
bilized anti-CD3 and anti-Tac antibodies. Both stimuli (Figure 2B). The lack of coimmunoprecipitation indicates
caused the downregulation of the TCR and TTz (Figure that the comodulation of the TCR complex and the TTz
1B, resting), suggesting that the comodulation effect chimera does not require their physical interaction. This
was independent of the proliferation state. Interestingly, finding is supported by previous studies demonstrating
in resting cells the downregulation of the unoccupied the absence of association between CD3z chimeras and
TTz chimera does not surpass the downregulation of the TCR complex in TTz transgenic mice (Shinkai et al.,
the directly engaged TCR upon anti-CD3 stimulation. 1995) and more recently in transgenic mice expressing
an IAs-z chimera (Geiger et al., 1999).The results shown in Figures 1A and 1B demonstrate
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Figure 1. The TCR Complex and the TTz Chimera Are Downregulated in a Coordinated Fashion in TTz Transgenic Mice
(A) Comodulation of the TCR complex and the TTz chimera. TTz transgenic concanavalin A (Con A) blasts were prepared from the spleens
of 4-week-old TTz transgenic mice. A total of 5 3 105 cells/200 ml/well were stimulated in 96-well plates coated with anti-Tac (MAR 108) or
anti-CD3e (145-2C11) at 50 mg/ml for 2 hr or mock stimulated (control). For each condition, cells were stained with H57-597 (for TCR expression)
or MAR 108 (for TTz expression) antibodies and analyzed by flow cytometry.
(B) Resting and blast T cells were isolated and prepared from the spleens of 4-week-old TTz transgenic mice and then stimulated and prepared
for flow cytometry as in (A). As a control for the specificity of TCR comodulation, the expression of CD4 was also analyzed in blast cells. The
experiment has been repeated four times with similar results.
(C) SEB induces the comodulation of TTz in vivo. TTz transgenic mice were injected intravenously with 200 mg of SEB (stimulated) or with
PBS (control). Mice were sacrificed and the expression of TCR (Vb8) was evaluated by flow cytometry after staining with F23.1 monoclonal
antibody. The expression of TTz was analyzed within the Vb81 population by staining with MAR 108. This result was originated in duplicates
and is representative of three experiments performed under the same conditions.
Comodulation of the TCR Complex is dependent on signal transduction events, a Lck-defi-
cient Jurkat variant, JCaM1.6, CD8zb-expressing clonewith CD3z-Containing Chimeras Is
Dependent on Signal Transduction was compared to a wild-type, CD8zb-expressing Jurkat
clone. The comodulation of the TCR complex observedTo exclude possible effects of the CD25 moiety of the
TTz chimera, the comodulation of the TCR complex after following engagement of the CD8zb chimera was weaker
in the Lck-deficient clone than in the Lck1 Jurkat cloneantibody-mediated cross-linking was studied with Jur-
kat cells transfected with a chimera comprised of the (Figure 3A), suggesting that Lck and thus signal trans-
duction plays an important role in the comodulation.extracellular and transmembrane domains of CD8a cou-
pled to the second ITAM of CD3z. Thus, the induction The observed residual comodulation of the TCR com-
plex could be due to the participation of other Src familyof comodulation of the TCR complex after anti-Tac stim-
ulation is likely limited to the signal-transducing units kinases, such as Fyn, that play a partially redundant role
with Lck in initiation of the signaling cascade (Cantrell,of CD3z. The initiation of signal transduction is mediated
by Lck-promoted tyrosine phosphorylation in ITAMs (re- 1996; Alberola-Ila et al., 1997; Qian and Weiss, 1997).
Indeed, incubation with PP1, a potent and selective in-viewed by Cantrell, 1996; Alberola-Ila et al., 1997; Qian
and Weiss, 1997). To determine whether comodulation hibitor of Src kinases, completely blocked comodulation
of the TCR complex in both the Lck2 and Lck1 cellof the CD3z-containing chimeras and the TCR complex
Immunity
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Figure 2. The TCR Complex and the TTz Chimera Are Comodulated Independent of Physical Interaction
(A) Antigen, antibody, or superantigen stimulation cause the comodulation of TTz in Jurkat cells. A Jurkat TTz-expressing clone was incubated
with plastic-bound anti-Tac (25 mg/ml), soluble SEB (10 mg/ml), plastic-bound anti-CD3 (25 mg/ml), or DAP-DR1 cells preloaded with HA
307±319 peptide (35 mM). The expression of the chimera and the TCR complex over time was analyzed after staining with OKT3 (for TCR/
CD3 expression) or MAR 108 (for TTz expression). The antibody stimulus experiment has been repeated 14 times; SEB stimulus, 3 times; and
peptide antigen stimulus, 6 times with similar results.
(B) The TTz chimera and the TCR complex do not physically associate. Clone TTz was stimulated with soluble SEB for 5 min. Cells were
subsequently lysed in 1% Brij96. Immunoprecipitation was performed with either anti-Tac (MAR 108) or anti-CD3 antibodies (OKT3). The
immunoprecipitates were subjected to SDS-PAGE, transferred to nitrocellulose, and immunoblotted with the anti-CD3z antibody 448. The
positions of the reacting CD3z and the TTz chimera are indicated. This experiment has been repeated three times with identical results.
lines (Figure 3A). In contrast, the downregulation of the The Comodulation of the TCR Complex and
the TTz Chimera Does Not Involve Tyrosineengaged CD8zb chimera was not affected.
The effect of PP1 and other PTK inhibitors on comodu- Phosphorylation of Nonengaged Receptors
The first event detected upon engagement of the TCRlation of the TCR complex was also assayed in the TTz-
expressing cell clone. The PTK inhibitors studied in- complex or the TTz chimera is the tyrosine phosphoryla-
tion of ITAMs by Lck and Fyn (Cantrell, 1996; Alberola-cluded herbimycin A, a Src kinase inhibitor; piceatannol,
a Syk-family kinase inhibitor; and genistein, a more gen- Ila et al., 1997; Qian and Weiss, 1997). The effects of
Lck deficiency and specific PTK inhibitors demonstratederal PTK inhibitor. Each of these drugs strongly inhibited
comodulation of the TCR complex in cells stimulated in the previous experiments suggested the participation
of PTKs in comodulation (Figure 3). We therefore consid-with immobilized anti-Tac antibody but had no effect
on the downregulation of the directly engaged chimera ered the possibility that comodulation could be medi-
ated by the trans-phosphorylation of the nonengagedreceptor (Figure 3B). These results strongly suggest that
while the downregulation of the directly engaged chi- receptors by Src family PTKs activated by the triggered
receptors.mera was PTK independent, the comodulation of the
TCR complex induced upon TTz cross-linking is PTK To test this hypothesis, we measured phosphorylation
in the stimulated TTz-expressing Jurkat clone (Figuredependent. In fact, this finding was seen regardless of
which receptor was directly engaged, since PP1 treat- 4). The TTz-expressing clone was stimulated with immo-
bilized anti-Tac antibody, and then the TTz chimera orment also completely inhibited comodulation of the TTz
chimera attained upon TCR triggering by anti-CD3 the TCR complex was immunoprecipitated and immu-
noblotted with an anti-phosphotyrosine antibody. While(shown in Figure 5A). Additional signal transduction in-
hibitors such as the PI 3-kinase inhibitor wortmannin cross-linking of the TTz chimera with antibody resulted
in the phosphorylation of its tyrosine residues, the tyro-and the PKC inhibitor bisindolylmaleimide also reduced
the level of comodulation of the TCR complex and CD3z sine residues on the CD3 subunits were not phosphory-
lated above unstimulated levels (Figure 4A). Incubationchimeras following cross-linking of the chimeric recep-
tor or TCR complex, respectively (data not shown). with pervanadate, a tyrosine phosphatase inhibitor, in-
creased the tyrosine phosphorylation of the CD3z (inThese results suggest that intracellular signals involving,
at least, PTKs, PKC, and PI 3-kinase mediate the ob- both its 23 kDa and 21 kDa forms) and CD3e chains,
but again, cross-linking of TTz in pervanadate-treatedserved comodulation effects elicited by TTz or TCR en-
gagement. cells did not elicit increased tyrosine phosphorylation
Activation-Dependent TCR Transmodulation
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Figure 3. The Downmodulation of Nonengaged Receptors Is Dependent on Signal Transduction
The effect of each drug on downregulation was measured following various periods of stimulation with plastic-bound OKT8 or anti-Tac
antibodies. For each drug used, cells were pretreated for 1 hr, and drug treatments continued throughout the stimulation period.
(A) The Lck2 JCam1.6 cell line transfected with CD8zb was studied in parallel with the Lck1 CD8zb clone. Cells were pretreated with 20 mM
PP1 (a Src kinase inhibitor) and subsequently stimulated with plastic-bound OKT8 antibody. Surface expression of TCR and CD8zb was
analyzed by flow cytometry after staining with OKT3 and OKT8 antibodies, respectively.
(B) The TTz clone was pretreated with 200 mM genistein, a wide-spectrum protein kinase inhibitor; 3 mM herbimycin A, a Src kinase inhibitor
(pretreated overnight); 100 mM piceatannol, a Syk kinase inhibitor; or 20 mM PP1. Cells were stimulated with immobilized anti-Tac antibody
in the presence of inhibitors and then stained with OKT3 and MAR 108 for surface expression of the TCR complex and the TTz chimera,
respectively. Finally, stained cells were analyzed by flow cytometry. The experiments with inhibitors have been repeated 14 times with similar
results.
of CD3 subunits. Equivalent loading control for both A PTK-Dependent Mechanism Promotes
the Downregulation of the TCR Compleximmunoprecipitates was demonstrated by reprobing the
membrane with an anti-z antibody that recognizes both at Low Concentrations of Ligand
The induced comodulation of the entire TCR complexthe TTz chimera and the CD3z subunit.
Stimulation of the TTz-expressing clone with SEB, by the stimulation of a chimera, which contains the sig-
naling domain of one of the CD3 subunits, raises thethus directly engaging the TCR complex, resulted in the
tyrosine phosphorylation of the CD3z and CD3e subunits possibility that ligand engagement of the TCR complex
may also initiate comodulation of other unengaged TCRbut not the trans-phosphorylation of TTz (Figure 4B).
Again, although pervanadate treatment elicited an in- complexes. Since comodulation of CD3z chimeras and
the TCR complex is dependent on PTK activity (Figurecreased basal tyrosine phosphorylation of the CD3 sub-
units and the TTz chimera, the combined treatment with 3), we tested the ability of a PTK inhibitor, PP1, to inhibit
the comodulation of bystander TCR complexes at in-SEB and pervanadate did not enhance phosphorylation
of the chimera. These results show that the comodula- creasing concentrations of stimuli. A PP1 concentration
was used that completely blocked tyrosine phosphory-tion of the TCR complex and the TTz chimera does not
involve trans-phosphorylation of the receptors by the lation of protein substrates stimulated by TCR cross-
linking, even at high concentrations of stimulus, andactivated PTKs.
Figure 4. The Comodulation of the TCR
Complex and the TTz Chimera Does Not In-
volve the trans-Phosphorylation of Tyrosine
Residues on Both Receptors
Clone TTz was stimulated with (A) soluble
anti-Tac antibody (25 mg/ml) or (B) soluble
SEB (20 mg/ml) in the presence or absence
of pervanadate for 5 min. Cells were subse-
quently lysed in 1% Brij96 and immunopre-
cipitation was performed with anti-Tac (MAR
108) or anti-CD3 (OKT3) antibodies. The im-
munoprecipitates were subjected to SDS-
PAGE, transferred to nitrocellulose, and im-
munoblotted with anti-phosphotyrosine (4G10).
The blots were then reprobed by a loading
control, anti-CD3z (448), which detects total
CD3z and TTz. This experiment has been re-
peated three times with similar results.
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prevented the induction of activation events such as the
induction of the early activation marker CD69 (data not
shown). The inhibition by PP1 of immobilized anti-CD3-
induced TCR downregulation was tested in Jurkat cells
(Figure 5A) and in TTz transgenic resting T cells (Figure
5B). In the absence of an inhibitor, TCR was downregu-
lated in an exponential fashion. The effect of PP1 varied
with the ligand concentration. At low concentrations of
anti-CD3 antibodies (0.1±1 mg/ml for Jurkat cells, 1±6
mg/ml for spleen T cells), PP1 completely blocked the
downregulation of the TCR complex. This effect dimin-
ished as the ligand concentration increased, and the
inhibitor was completely ineffective at concentrations
of or above 10 mg/ml for Jurkat cells and 30 mg/ml for
spleen T cells. In contrast, the sensitivity to PP1 of TTz
comodulation in both Jurkat cells (Figure 5A) and trans-
genic spleen T cells (Figure 5B) was independent of
the dose of anti-CD3 antibody. This result implies that
comodulation but not downregulation of the directly en-
gaged receptor is always PTK mediated.
The effect of PP1 inhibition on the downregulation of
the TCR complex at different concentrations of ligand
was also studied in the TTz clone stimulated with differ-
ent concentrations of HA 307±319 peptide presented by
DAP-DR1 cells (Figure 5C). As in the case of antibody
stimulation, TCR downregulation was completely inhib-
ited by PP1 at low concentrations of peptide (1 mM) but
was refractory to PP1 inhibition at high concentrations
(60 mM).
These results suggest that the TCR complex is down-
regulated by at least two mechanisms: one PTK-depen-
dent mechanism that predominates at low ligand con-
centrations and another PTK-independent mechanism
that predominates at high ligand concentrations. At low
ligand concentrations, where only a few directly en-
gaged receptors would be downregulated by the PTK-
independent mechanism, the overall phenotype would
appear to be PTK dependent like the CD3z chimera
cross-linking-induced trans-acting downregulation of
the TCR. However, at high ligand concentrations with Figure 5. The TCR Complex is Downregulated by at Least Two Dis-
tinct Mechanisms, of which One Is Signal Dependent and the Othermaximal receptor occupancy, a predominant phenotype
Is Signal Independentof PTK-independent comodulation would emerge.
(A) Jurkat TTz clone was incubated at 378C for 3 hr in culture wells
precoated with increasing concentrations of OKT3 in the presence
Discussion and absence of 20 mM PP1. The percentage of TCR downregulation
and TTz comodulation in both conditions was calculated from the
In this study we have determined that antibody-medi- mean fluorescence intensity values after staining with OKT3 and
MAR 108, respectively. This experiment has been repeated fiveated engagement of CD3z chimeras, which represent a
times with similar results.simplified form of the TCR complex, causes the comod-
(B) The same experiment was repeated with resting spleen cellsulation of bystander TCR complexes. Conversely, en-
from TTz transgenic mice stimulated for 6 hr on anti-CD3 (145-
gagement of the TCR complex by antigen, superantigen, 2C11)-coated wells. The expression of the TCR complex and the
or antibodies causes the comodulation of the CD3z chi- TTz chimera was analyzed after staining with H57-597 and MAR
meras. This comodulation is dependent on intracellular 108, respectively. This experiment has been repeated four times
with similar results.signaling pathways involving PTKs and not on direct
(C) Clone TTz was pretreated for 1 hr with 20 mM PP1 or mockphysical interaction between the TCR complex and the
treated and incubated on DAP-DR1 fibroblasts preloaded with thechimeras. The observed comodulation effect between
indicated concentrations of HA 307±319 peptide for an additional
the CD3z chimeras and the TCR complex suggests that hour. The surface expression of the TCR complex was analyzed by
engagement of the TCR complex can also lead to down- flow cytometry after staining with OKT3. This experiment has been
regulation of nonengaged receptors. The signaling path- repeated three times with similar results.
ways activated by CD3z chimeras seem identical to
those activated by the complete TCR (Irving and Weiss,
1991; Shinkai et al., 1995; Geiger et al., 1999). Therefore, conceivable that engagement of the CD3z-containing
TCR complex should also lead to the downregulationif engagement of the CD3z-containing chimera leads
to the downregulation of the noncontacted TCR, it is of nonengaged TCRs. Our results challenge the serial
Activation-Dependent TCR Transmodulation
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Figure 6. Downregulation Model for the TCR
Complex
Engagement of the TCR complex by its MHC
antigen ligand results in the internalization of
the complex by different mechanisms. Di-
rectly engaged receptors are internalized by a
signal transduction±independent mechanism
that may require the aggregation of the re-
ceptor, whereas nonengaged, bystander re-
ceptors are internalized as a consequence of
the activation of intracellular signaling path-
ways. The TCR complex is depicted as a
superdimer containing two TCRa/b modules
(San JoseÂ et al., 1998; Fernandez-Miguel et
al., 1999).
triggering hypothesis (Valitutti et al., 1995; Viola and signaling pathways in downregulation through the medi-
ation of PTKs, including Src and Syk family kinases,Lanzavecchia, 1996; Valitutti and Lanzavecchia, 1997),
which attempts to explain the observation that the num- PKC kinase, and PI 3-kinase. However, it is unclear how
the effect is specifically restricted to the TCR and itsber of downregulated TCR complexes far exceeds the
number of specific MHC/Ag complexes presented to components. Our data show that trans-phosphorylation
of tyrosine residues in the comodulated receptor is notthe T cell. The major support for the serial triggering
hypothesis is based on the observation that a T cell involved. Since the PKC inhibitor blocks comodulation,
it is possible that the activation of PKC results in TCRexpressing two TCRs with different specificities demon-
strates downregulation of only the TCR specifically en- downregulation through phosphorylation of CD3g in ser-
ine residues (Dietrich et al., 1994). However, this possiblegaged, i.e., there is no downregulation of the nonen-
gaged, bystander TCR (Valitutti et al., 1995). Thus, the mechanism does not explain how PKC is involved in
downregulation of the TTz chimera since CD3z does notnumber of engaged receptors should equal the number
of downmodulated receptors. Other authors have also contain PKC phosphorylation sites. We propose that
rather than mediating the phosphorylation of TCR sub-failed to detect comodulation of nonengaged receptors
in T cells expressing two TCRs (Stotz et al., 1999). Not- units, activation signals emanating from the engaged
receptors mediate the comodulation of nonengaged re-withstanding, these results have been challenged by
several other authors who have demonstrated comodu- ceptors via modification of the endocytic machinery.
This mechanism has been demonstrated previously inlation of bystander receptors (Exley et al., 1995; Nieder-
gang et al., 1997; Fernandez-Miguel et al., 1999). Fur- EGF receptor downregulation, where EGF binding to
its receptor causes the redistribution of clathrin heavythermore, a careful examination of the data by Palmer
and colleagues (Stotz et al., 1999) and Valitutti and Lan- chain to the cell periphery and endocytosis of the re-
ceptor (Wilde et al., 1999). This effect is mediated byzavecchia (Valitutti et al., 1995) shows some degree (up
to 50%) of comodulation of the bystander receptor. Src-dependent phosphorylation of a tyrosine residue
controlling polymerization of clathrin. Given this newSince the comodulation effect is favored when both re-
ceptors are expressed at similar levels, the discrepancy information, we are currently attempting to determine
whether activation of Lck and Fyn by the CD3z chimerasin the levels of comodulation detected in previous stud-
ies may be due to the unequal expression of the engaged and the TCR results in the tyrosine phosphorylation of
clathrin heavy chain. Irregardless of the presence orand nonengaged receptors on the cell surface. Further,
experiments performed with cells bearing two distinct absence of clathrin phosphorylation, additional mecha-
nisms must be invoked in order to explain the specificityTCRs pose the added complexity that the TCR complex
may consist of dimers of TCR heterodimers (Exley et of coreceptor recruitment. Perhaps the simultaneous
modification of several components of the general endo-al., 1995; San JoseÂ et al., 1998; Fernandez-Miguel et al.,
1999). If the two types of receptors physically associate, cytic machinery may restrict the trans-acting comodula-
tion effect to the TCR.comodulation of the nonengaged TCR could result from
receptor±receptor interaction rather than from a trans- The role of PTKs in downregulation of the TCR com-
plex raises some controversy. PTK inhibitors have beenacting effect. Therefore, demonstration of comodulation
of nonengaged TCRs in the absence of physical interac- shown to both inhibit (Luton et al., 1994; Martin and
Bevan, 1998) and not affect (Cai et al., 1997; Salio et al.,tion between receptors is allowed by the use of chimeras
expressing only the cytoplasmic domain of CD3z, which 1997) TCR internalization induced upon antibody- and
antigen-mediated triggering. Our results indicate thatis not involved in maintaining interactions within the TCR
complex (Frank et al., 1990; Rutledge et al., 1992; Shores the TCR complex can be downregulated by a combina-
tion of PTK-dependent and -independent mechanisms.et al., 1994).
We definitively demonstrate that comodulation of by- PTK-dependent mechanisms predominate at low con-
centrations of ligand, and downregulation of the TCRstander receptors occurs in our model. In an effort to
uncover the mechanism of this downregulation, we per- under these conditions can be entirely abrogated by
treatment with PP1 (Figures 5 and 6). This mechanismformed a series of pharmacological inhibition experi-
ments that demonstrate the involvement of intracellular is responsible for the downregulation of nonengaged
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HA 1.7, a T cell clone specific for influenza hemagglutinin peptidereceptors. In contrast, at high concentrations of ligand,
307±319 (Niedergang et al., 1997). This cell line was additionallydownregulation of the TCR is completely refractory to
transfected with a chimeric gene encoding the extracellular andPP1 inhibition, suggesting that the ligand-engaged TCR
transmembrane domains of the human IL-2 receptor a chain (Tac)
can be downregulated by a PTK-independent mecha- fused to the cytoplasmic tail of the CD3z chain (Letourneur and
nism. It is likely that even at low concentrations of ligand, Klausner, 1991; Letourneur and Klausner, 1992). A TCRb-negative
when most of the TCR complex is downregulated by a variant (31-13 cells) of the human Jurkat T cell line (Alcover et al.,
1988) was stably transfected with the extracellular and transmem-PTK-dependent mechanism, the few directly engaged
brane domains of human CD8a coupled to the second ITAM of CD3zTCR complexes become downregulated in the PTK-
(zb) to produce the cell line E7bD3 (CD8zb clone). Expression of theindependent fashion. In line with this idea, PP1 inhibition
receptor was reestablished by transfection with a Vb6 TCRb chain
could be used to estimate the number of directly en- cDNA. A Jurkat mutant that lacks Lck expression, JCam1.6 (Gold-
gaged receptors. Preliminary experiments suggest that smith and Weiss, 1987), was also stably transfected with the CD8zb
the directly engaged TCR and CD3z chimeras are down- chimera. The murine fibroblast cell line DAP DR11, which is trans-
fected with human HLA class II DR1 molecules, was used to presentregulated by a mechanism independent from PTK activ-
SEB or HA peptide (Lechler et al., 1988).ity and rearrangement of the actin cytoskeleton but are
dependent on both energy and temperature (A. B. and
B. A., unpublished data). These findings are very much Mice
in agreement with the results described by Sprent and Transgenic mice expressing the TTz chimera were a kind gift of Dr.
Fred Alt (The Children's Hospital, Boston, MA; Shinkai et al., 1995).colleagues (Cai et al., 1997).
Spleen cells harvested from 4-week-old transgenic mice were usedThe present study suggests that T cells have evolved
as resting T cells or stimulated with concanavalin A (1 mg/ml) for 48a system to amplify downregulation signals to nonen-
hr and IL-2 (20 U/ml) for an additional 24 hr to generate blast cells.
gaged receptors. We hypothesize that this PTK-depen- The effect of SEB stimulation on downregulation of TTz in vivo was
dent amplification mechanism would serve the purpose studied by intravenous injection of 200 mg SEB in PBS or in PBS
of terminating T cell activation signals when T cells are alone in 4-week-old transgenic mice. After 1 hr, the spleen cells
activated by a low number of agonists. In addition, non- from SEB-treated and control mice were harvested and analyzed
by flow cytometry.engaged downregulated TCRs may have previously par-
ticipated in T cell signaling, as suggested by evidence
in superantigen-activated cells (Niedergang et al., 1998). Antibodies and Chemicals
The existence of two mechanisms for downregulation, Staphylococcus aureus enterotoxin B (SEB) was obtained from
Toxin Technology. Mouse monoclonal antibodies directed againstone that operates at high concentrations of ligand and
human CD8a and CD3, OKT8, and OKT3, respectively, were ob-results from direct engagement and another that oper-
tained from Ortho Diagnostics Systems. The anti-Tac antibody, MARates at low concentrations and results from ªsignal
108, was generously provided by Dr. M. LoÂ pez-Botet (Hospital despreadingº to neighboring receptors, would be consis-
la Princesa, Madrid, Spain). The antibody specific for CD3z, Ab 448,
tent with the lateral spreading model of Bray and col- was generated by immunization of a New Zealand rabbit with a
leagues (Bray et al., 1998). These authors proposed that synthetic peptide corresponding to the 109±132 amino acid se-
ªa combination of low threshold of response and wide quence of human CD3z coupled to keyhole limpet hemocyanin. The
anti-phosphotyrosine antibody, 4G10, was acquired from Upstatedynamic range can be attained if the cell has both clus-
Biotechnology. The hamster anti-mouse CD3e, 145-2C11, was aters and single receptors on its surface.º The ªinfectiv-
generous gift of Dr. Jeff Bluestone (University of Chicago). FITC-ityº initiated by ligand-engaged TCR complexes to unoc-
conjugated antibodies specific for mouse and hamster Igs werecupied receptors provides a framework for amplifying
purchased from Southern Biotechnology. FITC-conjugated antibod-
the responses at low concentrations of ligand. Concur- ies specific for mouse TCRb (H57-597), mouse Vb8 (F23.1), and
rently, the signal transduction±independent mechanism mouse CD4 were purchased from PharMingen. All inhibitors used
provides the basis for extending the range of the re- in this study (PP1, genistein, herbimycin A, piceatannol, bisindolyl-
maleimide I, and wortmannin) were purchased from Calbiochem.sponse at high concentrations of ligand.
The trans-modulation effect demonstrated in the pres-
ent study provides an example of intracellular communi- Downregulation Experiments
cation between different TCR complexes. Interestingly, Antibody-coated plates were generated by incubating plastic 96-
well plates (Costar) overnight at 378C with 100 ml/well of the appro-Dittel and colleagues have recently demonstrated the
priate antibody (25 mg/ml) in PBS and washing with PBS before use.existence of a functional cross-inhibition involving a de-
Total bound antibodies under these conditions were estimated ascrease in the enzymatic activity of Lck associated to
20 ng per well by radiochemical procedures. Cells were adjustedunengaged TCRs (Dittel et al., 1999) in what could be
to 106/ml (105/well) in culture medium supplemented with 10 mM
considered another example of intracellular cross-talk. HEPES, pH 7.4, and incubated at 378C in wells previously coated
In summary, our work suggests that triggering the with the desired antibodies for the indicated time. The cells were
TCR complex or chimeras possessing one of its subunits then resuspended and transferred to ice-cold PBS and washed
twice. Afterwards, the cells were stained with the stimulating anti-causes the comodulation of nonengaged receptors. This
body followed by a FITC-conjugated secondary antibody. For co-comodulation effect appears confined to the TCR com-
modulation studies, cells were stained with the specific antibodyplex and is mediated by the activation of intracellular
directly labeled with FITC or PE. The samples were then analyzedsignaling pathways involving PTKs and other kinases.
in a Coulter XL Flow Cytometer and the mean fluorescence intensity
The mechanisms that mediate this trans-modulation ef- was measured at each point.
fect, which possibly involve the modification of the en- Antigen stimulation of the TTz clone was conducted by incubating
docytic machinery, are presently being investigated. the cells at 378C in the presence of HLA-DR1-transfected DAP mu-
rine fibroblasts (DAP-DR1) at an APC to T cell ratio of 1:1. APCs
were prepared by incubation overnight at 378C in 35 mM of influenzaExperimental Procedures
hemagglutinin peptide 307±319 in RPMI medium supplemented with
1% FCS. Stimulation with toxin superantigens was conducted byCells
incubating the cells at 378C in 10 mg/ml of soluble SEB at 378C forThe cell line CH7bRex TTz (TTz clone) is a previously described
Jurkat transfectant expressing the TCRa and b chains (Vb3.1) of the indicated periods of time.
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Immunoprecipitation and Western Blot Analysis Geiger, T.L., Leitenberg, D., and Flavell, R.A. (1999). The TCR zeta-
chain immunoreceptor tyrosine-based activation motifs are suffi-Cells were collected, washed, resuspended at 3 3 107 cells per ml
cient for the activation and differentiation of primary T lymphocytes.of RPMI supplemented with 10 mM HEPES, pH 7.4, and prewarmed
J. Immunol. 162, 5931±5939.at 378C for 10 min for each time point. Afterwards, either 10 mg/ml
SEB or anti-Tac was added for the specified incubation periods Goldsmith, M.A., and Weiss, A. (1987). Isolation and characterization
before cells were lysed in 1 ml of Brij96 lysis buffer containing of a T-lymphocyte somatic mutant with altered signal transduction
protease and phosphatase inhibitors (1% Brij96, 140 mM NaCl, 10 by the antigen receptor. Proc. Natl. Acad. Sci. USA 84, 6879±6883.
mM Tris±HCl [pH 7.8], 10 mM iodoacetamide, 1 mM PMSF, 1 mg/ Irving, B.A., and Weiss, A. (1991). The cytoplasmic domain of the T
ml leupeptin, 1 mg/ml aprotinin, 1 mM sodium orthovanadate, and cell receptor zeta chain is sufficient to couple to receptor-associated
20 mM sodium fluoride). Immunoprecipitation and immunoblotting signal transduction pathways. Cell 64, 891±901.
were performed as previously described (San JoseÂ et al., 1997).
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